<DOC>
	<DOC>NCT00065104</DOC>
	<brief_summary>This study's purpose is to learn how dehydroepiandrosterone (DHEA) affects the HIV virus, the immune system, hormone levels, body composition and quality of life.</brief_summary>
	<brief_title>Dehydroepiandrosterone Effects on HIV-1 Replication</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>Inclusion criteria: Evidence of HIV1 infection HIV RNA &lt;50 copies/mL Stable antiretroviral treatment regimen for at least 8 weeks Age 18 years or older Normal pap smear and mammograph within 1 year (females) Normal prostatespecific antigen level with in one year, age adjusted (males) Exclusion criteria: Active opportunistic infections or malignancy other than localized cutaneous KS lesions Concurrent or prior use within the past 8 weeks of DHA, testosterone, other anabolic steroids, corticosteroids, megestrol acetate, growth hormone, IL2, or thalidomide Diagnosis of AIDS Dementia Complex (stage II or higher) Active substance abuse (e.g., alcohol or injection drugs) Evidence of severe liver dysfunction or hepatic transaminases greater than 3x the upper normal limit Pregnant or breastfeeding History of endocrinologicallyresponsive tumors (e.g., breast, ovarian, uterine, or prostatic cancer, or malignant melanoma)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>HIV</keyword>
	<keyword>DHEA</keyword>
	<keyword>immune system</keyword>
	<keyword>hormones</keyword>
	<keyword>body composition</keyword>
	<keyword>quality of life</keyword>
</DOC>